Re: Unregistered Sales of Equity Securities and Use of Proceeds
in response to
by
Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: Re: Unregistered Sales of Equity Securities and Use of Proceeds
Jan 16, 2007 01:34PM
Jan 16, 2007 01:35PM
Your Vote:
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
PLUS:
During December 2006 and January 2007, the Company purchased 3,132,500 shares of its common stock at an aggregate cost of $1,960,305 under its stock buyback program. <?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:of... />
Another good move.
Loading...
Loading...
Jan 16, 2007 02:20PM
Jan 16, 2007 04:19PM
New Message
Please
login
to post a reply